Atherosclerosis and Angiogenesis: Its Pathophysiological Significance in Humans as Well as in an Animal Model Induced by the Gene Transfer of Vascular Endothelial Growth Factor a

Newly formed blood vessels have been observed in the atherosclerotic plaques of the human coronary arteries.'-' Attention has recently refocused on the role of new blood vessels in the progression and regression of atherosclerotic foci, especially in relation to plaque rupture, thrombus formation, and coronary ~ p a s m . ~ ~ However, there are still some unresolved problems, such as the origin of newly formed blood vessels and the angiogenic machanism(s) in the atherosclerotic intima and their pathophysiologic significance, because there have been a few quantitative studies8 performed so far concerning either the distribution of these new vessels within the atherosclerotic intima or the correlation between the histologic alterations and the preferential occurrence of intimal neovascularization. Moreover, there have been few reports on an animal model of either intimal angiogenesis9 or hemorrhagelo in arteriosclerotic arteries. It is well known that neovascularization is a ubiquitous and vital response in various physiologic and pathologic conditions, such as embryonic development,".'2 the inflammatory-repair process, proliferative diabetic re ti no path^,'^ and the growth of solid These angiogenic processes in vivo may involve various factors, especially growth factors and cytokines. In particular, vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF),'9g20 has recently been characterized as an angiogenic factor that is believed to be an endothelialspecific and hypoxia-inducible mitogen, which possesses a heparin-binding affinity

[1]  N. Kinukawa,et al.  Immunohistochemical localization of vascular endothelial growth factor in the human placenta. , 1996, Placenta.

[2]  J O McGee,et al.  Cytokine regulation of angiogenesis in breast cancer: the role of tumor‐associated macrophages , 1995, Journal of leukocyte biology.

[3]  K. Sueishi,et al.  Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. , 1995, Human pathology.

[4]  G. Breier,et al.  Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells , 1995, FEBS letters.

[5]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[6]  S M Schwartz,et al.  Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.

[7]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[8]  N. Olsen,et al.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.

[9]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[10]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[11]  D. Connolly,et al.  Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. , 1993, Kidney international.

[12]  E. Nabel,et al.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.

[13]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[14]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[15]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[16]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[17]  J. Winer,et al.  The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. , 1991, Molecular endocrinology.

[18]  J. Winer,et al.  Aortic smooth muscle cells express and secrete vascular endothelial growth factor. , 1991, Growth factors.

[19]  H. Dvorak,et al.  Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.

[20]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[21]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[22]  M. Nakamura,et al.  Intramural hemorrhage and endothelial changes in atherosclerotic coronary artery after repetitive episodes of spasm in x-ray-irradiated hypercholesterolemic pigs. , 1989, Circulation research.

[23]  D. Crawford,et al.  Adaptation to arterial wall hypoxia demonstrated in vivo with oxygen microcathodes. , 1989, Atherosclerosis.

[24]  P. Myers,et al.  Carotid intraplaque hemorrhage: the significance of neovascularity. , 1987, Journal of vascular surgery.

[25]  J. Marx Angiogenesis research comes of age. , 1987, Science.

[26]  S. Efremidis,et al.  Vasa vasorum in coronary-artery disease. , 1984, The New England journal of medicine.

[27]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[28]  G. Vincent,et al.  Coronary spasm producing coronary thrombosis and myocardial infarction. , 1983, The New England journal of medicine.

[29]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[30]  F. D. Mann Vasa Vasorum and Coronary Atherosclerosis , 2015, Lancet.

[31]  Alwin M. Pappenheimer,et al.  The Biology of Arteriosclerosis , 1938, The Yale Journal of Biology and Medicine.